Literature DB >> 23563241

Neopterin: a potential marker in chronic peripheral arterial disease.

Salvatore Santo Signorelli1, Massimiliano Anzaldi, Valerio Fiore, Saverio Candido, Roberto Di Marco, Katia Mangano, Cinzia Quattrocchi, Sergio Neri.   

Abstract

Neopterin is a marker of macrophage activation that has exhibited high plasma levels in atherosclerotic diseases including coronary heart disease and critical limb ischemia. The role of neopterin in chronic peripheral arterial disease (PAD) has yet to be elucidated. In the present study, neopterin (Ν) serum concentrations were analyzed in asymptomatic (AsP) and symptomatic (SyP) patients with PAD as well as controls (C). In total 120 subjects, 40 AsP [ankle brachial index (ABI) ≤0.90], 40 SyP (ABI ≤0.90 plus pain in legs) and 40 controls (ABI >0.9) were enrolled. The results of the present study showed that neopterin plasma levels were statistically different among the groups. These findings demonstrated that activation of N‑mediated monocyte‑macrophage, was also observed in chronic PAD.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23563241     DOI: 10.3892/mmr.2013.1407

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  3 in total

Review 1.  Neopterin, Inflammation, and Oxidative Stress: What Could We Be Missing?

Authors:  Steven P Gieseg; Gregory Baxter-Parker; Angus Lindsay
Journal:  Antioxidants (Basel)       Date:  2018-06-26

2.  New Insights in Prevention and Treatment of Cardiovascular Disease.

Authors:  Domenico Di Raimondo; Gaia Musiari; Giuliana Rizzo; Edoardo Pirera; Salvatore Santo Signorelli
Journal:  Int J Environ Res Public Health       Date:  2022-02-21       Impact factor: 3.390

Review 3.  Circulating Biomarkers in Lower Extremity Artery Disease.

Authors:  Louise Ziegler; Ulf Hedin; Anders Gottsäter
Journal:  Eur Cardiol       Date:  2022-03-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.